Close

Teva Pharma (TEVA) PT Lowered to $43 at Deutsche Bank

May 12, 2017 6:31 AM EDT Send to a Friend
Deutsche Bank lowered its price target on Teva Pharma (NYSE: TEVA) to $43.00 (from $45.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login